Vimarsana
Biggest News Aggregation in the World

Timur Yusufzai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timur Yusufzai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timur Yusufzai Today - Breaking & Trending Today

DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY - Vimarsana News

DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY

Published: March 2, 2023

/PRNewswire/ -- Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments...

Source: prnewswire.com
Related Topics:
Bertrand DucreyConnor ClairmontDavid KozonoEli RothenbergJessicac LiuDavid FenyoZheng LiEmilyf GaudianoPrnewswire DebiopharmKarthikeyan PonnienselvanAngela ZubelLeng LuiTimur YusufzaiLarissa Alina SambelChunyu YangEmmaa RobertsSarah KeeganKatee ColemanDuncanj SmithTonyt HuangnatAland DandreaHead Of CommunicationsCell Nuclear AntigenDebiopharm InternationalNovo Nordisk
Debiopharm International SA: DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY - Vimarsana News

Debiopharm International SA: DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY

Published: March 2, 2023

Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor LAUSANNE, Switzerland, March 2, 2023 /PRNewswire/ -- Debiopharm

Source: finanznachrichten.de
Related Topics:
Dennis RiedlBertrand DucreyConnor ClairmontDavid KozonoEli RothenbergJessicac LiuDavid FenyoZheng LiEmilyf GaudianoPrnewswire DebiopharmKarthikeyan PonnienselvanAngela ZubelLeng LuiTimur YusufzaiTonyt HuangLarissa Alina SambelChunyu YangEmmaa RobertsSarah KeeganKatee ColemanDuncanj SmithAland DandreaHead Of CommunicationsCell Nuclear AntigenNovo Nordisk